We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

202 hedge funds and large institutions have $1B invested in Immunogen Inc in 2022 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 69 increasing their positions, 67 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% more call options, than puts

Call options by funds: $6.78M | Put options by funds: $3.42M

6% more capital invested

Capital invested by funds: $942M → $1B (+$61.2M)

3% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 67

9% less funds holding

Funds holding: 222 → 202 (-20)

41% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 44

Holders
202
Holders Change
-20
Holders Change %
-9.01%
% of All Funds
3.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
69
Reduced
67
Closed
44
Calls
$6.78M
Puts
$3.42M
Net Calls
+$3.35M
Net Calls Change
-$1.16M

Top Buyers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
+$27.3M
2
MC
Maverick Capital
Texas
+$18M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$17.5M
4
Jennison Associates
Jennison Associates
New York
+$16M
5
State Street
State Street
Massachusetts
+$15.8M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$40M
2
ClearBridge Investments
ClearBridge Investments
New York
-$23.1M
3
Renaissance Technologies
Renaissance Technologies
New York
-$8.15M
4
Citadel Advisors
Citadel Advisors
Florida
-$7.67M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$6.76M

IMGN Hedge Fund Activity: Q4 2022 in Review

202 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q4 2022, worth a combined $1B — up 6.5% from $942M a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of IMGN and 26 opened new positions — a net loss of 18 holders — while 67 trimmed existing stakes and 69 added.

The largest buyer was Woodline Partners, opening a new position worth an estimated $27.3M. The largest seller was Deerfield Management, cutting an estimated $40M.

  • 202 institutional investors held Immunogen Inc (IMGN) as of Q4 2022, down from 222 in Q3 2022.
  • Funds reported $1B of Immunogen Inc stock for Q4 2022, up 6.5% quarter-over-quarter.
  • 26 funds opened new Immunogen Inc positions in Q4 2022 and 44 closed out, a net change of -18 holders.
  • The largest Immunogen Inc buyer in Q4 2022 was Woodline Partners, an estimated $27.3M added.
  • The largest Immunogen Inc seller in Q4 2022 was Deerfield Management, an estimated $40M sold.

Based on aggregated 13F filings for Q4 2022.